Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma. [electronic resource]

By: Contributor(s): Publication details: OncoTargets and therapy 2017Description: 447-452 p. digitalISSN:
  • 1178-6930
Online resources: In: OncoTargets and therapy vol. 10
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.